Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Paclitaxel in NSCLC
NCT01024062Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Dec 2002
- Primary completion
- Mar 2005
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection in non-small cell lung cancer (NSCLC), sponsored by Bristol Myers Squibb. Started Dec 2002; status: completed.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01024062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01024062.